Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...
Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Portland General Electric Company’s $434 Million Common Stock Offering
Latham & Watkins represented Portland General Electric Company in the offering, while Davis Polk acted as counsel to the representatives of the underwriters. Portland General Electric Company...
Skydance Media’s $400 Million Financing Round
Latham & Watkins represented Skydance in the transaction, while Paul, Weiss advised KKR. Skydance Media has completed a US$400 million strategic financing round led by KKR and joined...
ABB’s Carve-Out of Accelleron Industries Ltd.
White & Case, Cirio and Latham & Watkins advised ABB Ltd on the deal. Lenz & Staehelin advised ABB and Accelleron. ABB Ltd, a leading global...
Worthington Industries’ Steel Processing Business Spin-off
Latham & Watkins represented Worthington Industries in the transaction. Worthington Industries, Inc. (NYSE: WOR), a leading industrial manufacturing company, has announced that its Board of Directors unanimously...
Redbird Capital’s Sale of OneTeam Partners
Simpson Thacher represented OneTeam Partners, Latham & Watkins represented the NFL Players Association, Paul, Weiss advised HPS Investment Partners on the deal. RedBird Capital Partners sold its...
Alborz’s $46.9 Million Secured Credit Facility
Latham & Watkins advised Cipher Mining in the transaction. Alborz LLC, a joint venture affiliate of Cipher Mining Inc. (NASDAQ: CIFR) and WindHQ LLC, has announced...
DigitalBridge Investment Management and IFM’s $11 Billion Take-Private Acquisition of Switch
Latham & Watkins advised the Special Committee of the Board of Directors of Switch, and Simpson Thacher & Bartlett advised DigitalBridge and IFM on the deal....
Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...
Evergreen- and Brookfield-Led Consortium’s $16 Billion Acquisition of Nielsen
Wachtell, Lipton, Rosen & Katz, Clifford Chance LLP, DLA Piper, and Baker McKenzie represented Nielsen. Gibson, Dunn & Crutcher LLP and Herbert Smith Freehills LLP represented...
Ligand’s Spin-off of OmniAb Business
Latham & Watkins represented Ligand in the transaction, while Weil, Gotshal & Manges represented APAC. Ligand Pharmaceuticals Incorporated has announced the signing of a definitive merger...
Extra Space’s $400 Million Senior Notes Offering
Latham & Watkins represented Extra Space in the offering. Extra Space Storage Inc., a leading owner and operator of self-storage facilities in the United States and a...